[CUSIP No. 16938C106 Page 2 of 5 1 NAMES OF REPORTING PERSONS Chi Sing Ho 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Canada]
[CUSIP No. 16938C106 Page 2 of 5 1 NAMES OF REPORTING PERSONS Chi Sing Ho 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Canada]
[CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENT Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties] [INDEMNIFICATION AGREEMENT Company Indemnitee This Indemnification Agreement, dated as of March 19, 2012, is made by and between China Biologic Products, Inc., a Delaware corporation (the RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 23, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China (+86) 10-6598-3111 (Former name or former]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 21, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, (+86) 10-6598-3111 _______________________________________________ see Item 8.01. Other Events. CHINA BIOLOGIC PRODUCTS, INC. Chao Ming Zhao Chief Executive Officer]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 21, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, (+86) 10-6598-3111 _______________________________________________ see Item 8.01. Other Events. CHINA BIOLOGIC PRODUCTS, INC. Chao Ming Zhao Chief Executive Officer]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer ID No.) 18th Floor, Jialong International Building, (+86) 10-6598-3111 ____________________________________________________________ (Former name or former address, if changed since last report) see ITEM 5.02. DEPARTURE OF]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer ID No.) 18th Floor, Jialong International Building, (+86) 10-6598-3111 ____________________________________________________________ (Former name or former address, if changed since last report) see ITEM 5.02. DEPARTURE OF]
[REQUEST FOR STOCKHOLDER CONSENT TO ACTION Ms. Lin Ling Li lll@ctbb.com.cn DATED: MARCH 15, 2012 To : including all pages If you agree with the proposed action by written consent set forth herein, please sign the accompanying written consent which we will notify the Company in accordance with the Delaware General Corporation Law (the DGCL). Please return the signed written] [SCHEDULE 13D [Rule 13d-101] (Amendment No. 4)* CHINA BIOLOGIC PRODUCTS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 16938C106 (CUSIP Number) No. 14 East Hushan Road Tai'an City, Shandong 271000 People's Republic of China (86) 538-620-2306 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 14, 2012]
[REQUEST FOR STOCKHOLDER CONSENT TO ACTION Ms. Lin Ling Li lll@ctbb.com.cn DATED: MARCH 15, 2012 To : including all pages If you agree with the proposed action by written consent set forth herein, please sign the accompanying written consent which we will notify the Company in accordance with the Delaware General Corporation Law (the DGCL). Please return the signed written] [SCHEDULE 13D [Rule 13d-101] (Amendment No. 4)* CHINA BIOLOGIC PRODUCTS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 16938C106 (CUSIP Number) No. 14 East Hushan Road Tai'an City, Shandong 271000 People's Republic of China (86) 538-620-2306 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 14, 2012]
[FORM 10-K (Mark One) December 31, 2011 Commission File No. 001-34566 CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 18th Floor, Jialong International Building, 19 Chaoyang Park Road (+86) 10-6598-3111 Title of each class Name of each exchange on which registered Common Stock, par value $0.0001 per share NASDAQ Global] [The Board of Directors We consent to the incorporation by reference in the registration statement (No. 333-171069) on Form S-3 and the registration statement (No. 333-151263) on Form S-8 of China Biologic Products, Inc. of our reports dated March 12, 2012, with respect to the consolidated balance sheets of China Biologic Products, Inc. and subsidiaries as of December 31, 2011] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of We consent to the use of our report dated March 23, 2010, except for the effects on the consolidated financial statements of the restatement described in Note 2, as to which the date is March 31, 2011, with respect to the consolidated balance sheets of China Biologic] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Yu-Yun Tristan Kuo, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th (Principal Financial and Accounting Officer)]
